ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr.

In a report released yesterday, Etzer Darout from BMO Capital reiterated a Buy rating on Acrivon Therapeutics, Inc. (ACRV – Research ...

Canaccord Genuity analyst Whitney Ijem maintained a Buy rating on Passage Bio (PASG – Research Report) yesterday and set a price target ...

NASHVILLE, Tenn., November 12, 2024--(BUSINESS WIRE)--Sarah Cannon Research Institute (SCRI), one of the world’s leading ...

at 08:10 ICON plc to Present at the Jefferies London Healthcare Conference ICON plc, a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, ...

At this year’s Fall convocation ceremonies on Nov. 20 and 21, the university will honour the achievements of artist, poet and ...

Analysts are optimistic, shown by an upward trend in estimates, reflecting a growing confidence in ICON’s performance trajectory. ICON PLC’s stock recently closed at $212.18, with Stock Target Advisor ...

The company is recruiting for a second Phase 1 clinical trial (NCT06442761) that it’s running in collaboration with sponsor ...

The National Institute of Aging awarded a $7.3 million research grant for the study of NU-9 as a treatment for ...

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced a new enterprise agreement with Bioforum, a biometrics CRO that ...

The vaccine appears to be safe and effective against triple-negative breast cancer -- a type that can’t be treated with ...

This report offers a comprehensive analysis of the global cervical cancer research... Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today ...